Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma

被引：7
|
作者：
He, Zhen [1 ]
Wu, Xuan [1 ]
Ma, Shuxiang [1 ]
Zhang, Cuicui [1 ]
Zhang, Zhe [1 ]
Wang, Shuai [1 ]
Yu, Sheng [1 ]
Wang, Qiming [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Internal Med, 127 Dong Ming Rd, Zhengzhou 450008, Henan, Peoples R China
来源：
CLINICAL LUNG CANCER | 2019年 / 20卷 / 05期
基金：
芬兰科学院; 中国国家自然科学基金;
关键词：
C1156Y; Crizotinib; Next-generation sequencing; Sensitivity; WDPCP-ALK; ANAPLASTIC LYMPHOMA KINASE; PATIENT; GENE; IMMUNOHISTOCHEMISTRY; CANCER;
D O I：
10.1016/j.cllc.2019.06.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E548 / E551
页数：4
相关论文
共 50 条
  • [31] Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma
    Jang, Jin Sung
    Wang, Xiaoke
    Vedell, Peter T.
    Wen, Ji
    Zhang, Jinghui
    Ellison, David W.
    Evans, Jared M.
    Johnson, Sarah H.
    Yang, Ping
    Sukov, William R.
    Oliveira, Andre M.
    Vasmatzis, George
    Sun, Zhifu
    Jen, Jin
    Yi, Eunhee S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1891 - 1900
  • [32] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
  • [33] PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma
    Yang, Liangwei
    Zhao, Weidi
    Zhu, Huangkai
    Li, Xi
    Zhao, Guofang
    [J]. LUNG CANCER, 2021, 154 : 219 - 220
  • [34] Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing
    Xiaoyun Zhou
    Xiaohui Xu
    Zhenhuan Tian
    Wang-Yang Xu
    Yushang Cui
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2277 - 2287
  • [35] Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing
    Zhou, Xiaoyun
    Xu, Xiaohui
    Tian, Zhenhuan
    Xu, Wang-Yang
    Cui, Yushang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2277 - 2287
  • [36] HIP1-ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma
    Hong, Mineui
    Kim, Ryong Nam
    Song, Ji-Young
    Choi, So-Jung
    Oh, Ensel
    Lira, Maruja E.
    Mao, Mao
    Takeuchi, Kengo
    Han, Joungho
    Kim, Jhingook
    Choi, Yoon-La
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (03) : 419 - 422
  • [37] Validation of MET amplification using next-generation sequencing in lung adenocarcinoma
    Salido, M.
    Clave, S.
    Sanchez, I.
    Rocha, P.
    Pinto, L. Masfarre
    Gorro, N. Navarro
    Campos, M. A. Galindo
    Del Rey-Vergara, R.
    Garcia, A. Taus
    Espinet, B.
    Arriola, E.
    Paricio, B. Bellosillo
    [J]. ANNALS OF ONCOLOGY, 2023, 34
  • [38] Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
    Kazushige Wakuda
    Meiko Morita
    Motoki Sekikawa
    Noboru Morikawa
    Keita Miura
    Kosei Doshita
    Yuko Iida
    Hiroaki Kodama
    Nobuaki Mamesaya
    Haruki Kobayashi
    Ryo Ko
    Akira Ono
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Koji Muramatsu
    Takuya Kawata
    Keita Mori
    Tetsuo Shimizu
    Yasuhiro Gon
    Toshiaki Takahashi
    [J]. International Journal of Clinical Oncology, 2024, 29 : 96 - 102
  • [39] Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
    Wakuda, Kazushige
    Morita, Meiko
    Sekikawa, Motoki
    Morikawa, Noboru
    Miura, Keita
    Doshita, Kosei
    Iida, Yuko
    Kodama, Hiroaki
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Ko, Ryo
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Muramatsu, Koji
    Kawata, Takuya
    Mori, Keita
    Shimizu, Tetsuo
    Gon, Yasuhiro
    Takahashi, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 96 - 102
  • [40] A novel SETD3-ALK fusion in lung adenocarcinoma and sustained clinical response to crizotinib
    Dai, Shuang
    Liu, Xiao-Qin
    Wu, Qiang
    Du, Chun-Mei
    Liu, Qing
    Xue, Yin-Yin
    Luo, Feng
    Li, Yan
    [J]. LUNG CANCER, 2023, 175 : 121 - 124
12345